Central Nervous System Lymphoma — Trials

Central Nervous System Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

214 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 81
Recruiting: 54
Ph III recruiting: 5
Growth YoY: —
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 26.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05222269	[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients	terminated	Phase 2	1	Pentixapharm AGINDUSTRY	2	Sep 5, 2025	clinicaltrials
NCT06625359	High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma	terminated	Phase 2	17	Seoul National University HospitalOTHER	1	Oct 3, 2024	clinicaltrials